Pfizer (PFE) Tops Q2 EPS by 11c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.17 -0.33%
Revenue Growth %: -1.9%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: -1.9%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $1.07, $0.11 better than the analyst estimate of $0.96. Revenue for the quarter came in at $19 billion versus the consensus estimate of $18.45 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.95-$4.05, versus the consensus of $3.70. Pfizer sees FY2021 revenue of $78-80 billion, versus the consensus of $72.78 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
- Occidental Petroleum releases Q2 2026 earnings considerations
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
